$1.80
00.00%
At Close: -
$1.70
-0.1-5.56%
After Hours: 9:08 AM EDT
15 minutes delayed
Comments
Loading...
Lixte Biotechnology (NASDAQ:LIXT) Stock, Earnings Estimates, EPS, And Revenue
Lixte Biotechnology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 8
EPS
$-0.450
Quarterly Revenue
$0K
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Lixte Biotechnology using advanced sorting and filters.
Data brought to you by Benzinga APIs
Lixte Biotechnology (LIXT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Lixte Biotechnology (LIXT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Lixte Biotechnology (NASDAQ:LIXT) reporting earnings?
Lixte Biotechnology (LIXT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
What were the latest earnings per share (EPS) for Lixte Biotechnology (NASDAQ:LIXT)?
The Actual EPS was $-0.45, which missed the estimate of $0.00.
What were Lixte Biotechnology’s (NASDAQ:LIXT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.